Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Varadhan

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Annals of Internal Medicine|January 1, 2019
Statistical Code for Clinical Research PapersRavi Varadhan
Journal of the American Geriatrics Society|October 25, 2019
A Socratic Inquiry Into the Nature of FrailtyRavi Varadhan
Pharmaceutical Statistics|August 16, 2021
Addressing and communicating heterogeneous treatment effects for patient subpopulations: Challenges and opportunitiesRavi Varadhan
Statistics in Medicine|February 26, 2013
Model selection in competing risks regressionDeborah Kuk, Ravi Varadhan
JAMA|July 14, 2004
Risk-treatment paradox in use of statinsCarlos O Weiss, Ravi Varadhan
American Journal of Epidemiology|November 2, 2019
Segal and Varadhan Respond to "Estimation With Claims-Based Frailty Indexes"Jodi B Segal, Ravi Varadhan
American Journal of Epidemiology|April 22, 2026
Smoking hot joint models for attrition bias-XMAR-ks the spotMichael E Griswold, Ravi Varadhan
Epidemiology (Cambridge, Mass.)|November 1, 2002
Confidence intervals for seasonal relative risk with null boundary valuesConstantine E Frangakis, Ravi Varadhan
Biometrical Journal. Biometrische Zeitschrift|October 21, 2015
Treatment effect heterogeneity for univariate subgroups in clinical trials: Shrinkage, standardization, or elseRavi Varadhan, Sue-Jane Wang
Journal of Comparative Effectiveness Research|October 2, 2019
If we recognize heterogeneity of treatment effect can we lessen waste?Jodi B Segal, Ravi Varadhan
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Annals of Internal Medicine|January 1, 2019
Statistical Code for Clinical Research PapersRavi Varadhan
Journal of the American Geriatrics Society|October 25, 2019
A Socratic Inquiry Into the Nature of FrailtyRavi Varadhan
Pharmaceutical Statistics|August 16, 2021
Addressing and communicating heterogeneous treatment effects for patient subpopulations: Challenges and opportunitiesRavi Varadhan
Statistics in Medicine|February 26, 2013
Model selection in competing risks regressionDeborah Kuk, Ravi Varadhan
JAMA|July 14, 2004
Risk-treatment paradox in use of statinsCarlos O Weiss, Ravi Varadhan
American Journal of Epidemiology|November 2, 2019
Segal and Varadhan Respond to "Estimation With Claims-Based Frailty Indexes"Jodi B Segal, Ravi Varadhan
American Journal of Epidemiology|April 22, 2026
Smoking hot joint models for attrition bias-XMAR-ks the spotMichael E Griswold, Ravi Varadhan
Epidemiology (Cambridge, Mass.)|November 1, 2002
Confidence intervals for seasonal relative risk with null boundary valuesConstantine E Frangakis, Ravi Varadhan
Biometrical Journal. Biometrische Zeitschrift|October 21, 2015
Treatment effect heterogeneity for univariate subgroups in clinical trials: Shrinkage, standardization, or elseRavi Varadhan, Sue-Jane Wang
Journal of Comparative Effectiveness Research|October 2, 2019
If we recognize heterogeneity of treatment effect can we lessen waste?Jodi B Segal, Ravi Varadhan
Pageof 18